SOLICITATION NOTICE
U -- NHGRI Medical Genetics Training Program
- Notice Date
- 1/4/2016
- Notice Type
- Presolicitation
- NAICS
- 621511
— Medical Laboratories
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, Rockledge Dr. Bethesda, MD, Office of Acquisitions, 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, Maryland, 20892-7902
- ZIP Code
- 20892-7902
- Solicitation Number
- HHS-NIH-NHLBI-CSB-(HG)-2016-049-DM
- Archive Date
- 1/23/2016
- Point of Contact
- Dorothy Maxwell, Phone: 301-435-0352
- E-Mail Address
-
maxwelld@mail.nih.gov
(maxwelld@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- INTRODUCTION: THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). THIS IS A NOTICE OF INTENT, NOT A REQUEST FOR A PROPOSAL. A SOLICITATION DOCUMENT WILL NOT BE ISSUED AND PROPOSALS WILL NOT BE REQUESTED. The National Heart, Lung, and Blood Institute (NHLBI) Office of Acquisition (OA) on behalf of the National Human Genome Research Institute, (NHGRI), intends to negotiate and award a purchase order on a non-competitive sole source basis without providing for full and open competition to Quest Diagnostics Nichols Institute, 14225 Newbrook Drive, Chantilly, Virginia 20151-2228 to provide training opportunities for NHGRI Fellows in the Washington DC Metropolitan Genetics Fellowship Training Program. THIS IS A FOLLOW-ON REQUIREMENT Procurement : 1. Provide 9 Fellows for one month each: 5 in Cytogenetics and 4 in Molecular Genetics. Background: The National Institutes of Health (NIH) mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. The National Human Genome Research Institute (NHGRI) mission has expanded to encompass a broad range of studies aimed at understanding the structure and function of the human genome and its role in health and disease. To that end NHGRI supports the development of resources and technology that will accelerate genome research and its application to human health. Division of Intramural Research (DIR) was established to serve as a hub where development of technology for the rapid isolation and analysis of disease genes will be carried out. The DIR's basic research laboratories and clinical branches develop and use the most advanced techniques to conduct research in medical genetics. Research includes identifying and understanding the molecular basis of human genetic disease and planning and carrying out clinical trials to test methods for the treatment. The cytogenetic laboratory experience of the trainees must include routine karyotyping from peripheral blood in both children and adults, karyotyping of products of conception, prenatal diagnosis, cancer cytogenetics, and fluorescent in situ hybridization (FISH). The laboratory aspect of the training program will need to be conducted in cytogenetics diagnostic laboratories with equipment and personnel to provide the hand-on experience required for board certification by ABMG. The staff, which must include both ABMG board certified cytogeneticist(s) and a genetic counselor, will be required to train fellows in applicable laboratory techniques and the clinical interpretation and implications of the test results. The staff must also participate in the comprehensive teaching of fellows including participation in lecture series, journal clubs, and case conferences. A genetic counselor will assist in the training of fellows in the interpretation and genetic implication of tests they are learning to perform in these diagnostic laboratories. The molecular genetics laboratory experience of the trainees must include a wide array of molecular diagnostic testing in the fields of neurodegenerative disorders, late onset disorders, imprinting disorders, mental retardation, neuromuscular disorders, and metabolic diseases, including prenatal diagnosis. The laboratory aspect of the training program will need to be conducted in molecular diagnostic laboratories with equipment and personnel to provide the hands-on experience required for board certification by ABMG. The staff, which must include ABMG board certified laboratory directors, will be required to train fellows in applicable laboratory techniques and the clinical interpretation and implications of the test results. The staff must also participate in the comprehensive teaching of fellows including participation in lecture series, journal clubs, and case conferences. The cost of disposable supplies used by trainees will be included in the contract. Quest Laboratories provides training in Cytogenetics and Common Molecular Genetic Diagnostic Testing. This training is a segment of the mandated curriculum of the Washington DC Metropolitan Genetics Fellowship Training Program required for Board certification in Clinical Genetics, Clinical Biochemical Genetics, Clinical Cytogenetics and /or Clinical Molecular Genetics. This training must be provided in CLIA approved, diagnostic laboratories with expertise in this type of laboratory testing. Because most of these tests are diagnostic, for very rare disorders, these are the only labs that meet the American Board of Medical Genetics training criteria within a 40 mile radius of the NIH campus which will allow Fellows to maintain their responsibilities at the NIH Clinical Center and train in these settings. Purpose and Objective: The mission of the DIR includes the training of physicians and doctoral degree fellows in medical genetics through the Metropolitan Washington D.C. Medical Genetics Residency Program. The Metropolitan Washington D.C. Medical Genetics Residency Program is administered by the Office of the Clinical Director (OCD) and is accredited by the American Board of Medical Genetics (ABMG). Requirements for board certification of competency of our trainees include laboratory experiences in cytogenetics, biochemical genetics and molecular genetics. To meet these requirements, the Medical Genetics Branch and OCD seek nearby institutions to provide these components of training for board certification in Clinical Genetics, Clinical Biochemical Genetics, Clinical Molecular Genetics and Clinical Cytogenetics. This institution or group of institutions must also provide the opportunity for trainees to see patients with genetic disorders under the direction of an ABMG board certified geneticist. Other Important Considerations : The Government's minimum requirements are as follows: Specific tasks to be performed are: 1. Each year the training program will enroll up to four (4) clinical genetics fellows, (2) clinical biochemical genetics fellows, and (3) clinical molecular genetics fellows. Each fellow will spend one (1) month each in the cytogenetics and molecular genetics laboratories. 2. Track the progress of each fellow to insure that they will have had necessary experiences for ABMG certification. The Contractor shall establish and adhere to time lines for: 1. Providing all the required experiences for board certification with each month period. 2. Evaluating each fellow to insure they have a full understanding of all the techniques taught during training experiences. 3. Having sufficient samples submitted to the laboratory so that the fellows can have first-hand involvement in 150 cases of sufficient variety to qualify for ABMG Board eligibility. 4. Personnel qualifications are to be provided by the Contractor to the Project Officer for review and approval prior to the award of the contract. Period of Performance: 12-Months--Base Year 12-Months--Option 1 12-Months--Option 2 Regulatory Authority: This acquisition is conducted under the authority of the Federal Acquisition Regulations (FAR) Subpart 13.106-1(b) Soliciting from a single source and is not expected to exceed the simplified acquisition threshold, only one responsible source and no other supplies or services will satisfy agency requirements. Statutory Authority: This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Additional Information : Industry Classification (NAICS) Code is 621511, Medical Laboratories, and the Small Business Size Standard is $32.5M. The acquisition is being conducted under FAR Part 13, simplified acquisition procedures, therefore the requirements of FAR Part 6 B Competitive Requirements are not applicable (FAR Part 6.001). The resultant Contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 05-85-1 (January 4, 2016). This requirement is under the SAT of $150,000.00. This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by January 8, 2016 and must reference synopsis number HHS-NIH-NHLBI-CSB-(HG)-2016-049-DLM by 7:30 a.m. Eastern Time, may be submitted to the National, Heart, Lung and Blood Institute, Office of Acquisition, COAC Services Branch, 6701 Rockledge Drive, Suite 6149, Bethesda, Maryland 20892-7902, Attention: Dorothy Maxwell. Response may be submitted electronically to maxwelld@mail.nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency."
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NHLBI/HHS-NIH-NHLBI-CSB-(HG)-2016-049-DM/listing.html)
- Place of Performance
- Address: Contractor's Location, United States
- Record
- SN03982256-W 20160106/160104234220-664f5cd935109b6016e3dbb342531b28 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |